ErikW.GundersonMD

PubMed

• 13 citations
  Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial
  Lynn Webster, Peter Hjelmström, Michael Sumner, Erik W. Gunderson> ;Journal of Addictive Diseases. 2016 Jun 7
• 18 citations
  Effects of a Higher-bioavailability Buprenorphine/Naloxone Sublingual Tablet Versus Buprenorphine/Naloxone Film for the Treatment of Opioid Dependence During Induction...
  Erik W. Gunderson, Peter Hjelmström, Michael Sumner> ;Clinical Therapeutics. 2015 Oct 1
• 70 citations
  Designer drugs 2015: assessment and management.
  Michael F. Weaver, John A. Hopper, Erik W. Gunderson> ;Addiction Science & Clinical Practice. 2015 Mar 25
• 2 citations
  Recognizing Potential Buprenorphine Medication Misuse: Product Packaging Does Not Degrade With Laundering.
  Erik W. Gunderson> ;Substance Abuse. 2015 Mar 26
• 73 citations
  A survey of synthetic cannabinoid consumption by current cannabis users.
  Erik W. Gunderson, Heather M. Haughey, Nassima Ait-Daoud, Amruta Joshi, Carl L. Hart> ;Substance Abuse. 2014 Jan 1
• 3 citations
  Intranasal substituted cathinone "bath salts" psychosis potentially exacerbated by diphenhydramine.
  Erik W. Gunderson, Matthew G. Kirkpatrick, Laura M. Willing, Christopher P. Holstege> ;Journal of Addiction Medicine. 2013 May 1
• 19 citations
  Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking
  Bankole A. Johnson, John D. Roache, Nassima Ait-Daoud, Erik W. Gunderson, Heather M. Haughey, Xin-Qun Wang, Lei Liu> ;Addiction Biology. 2013 May 1
• 132 citations
  “Spice” and “K2” Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans
  Erik W. Gunderson, Heather M. Haughey, Nassima Ait-Daoud, Amruta Joshi, Carl L. Hart> ;The American Journal on Addictions. 2012 Jul 1
• 50 citations
  Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans.
  Matthew G. Kirkpatrick, Erik W. Gunderson, Chris-Ellyn Johanson, Frances R. Levin, Richard W. Foltin, Carl L. Hart> ;Addiction. 2012 Apr 1
• 9 citations
  Improving Temporal Efficiency of Outpatient Buprenorphine Induction
  Erik W. Gunderson, Frances R. Levin, Margaret M. Rombone, Suzanne K. Vosburg, Herbert D. Kleber> ;The American Journal on Addictions. 2011 Jul 18
• 55 citations
  Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study
  Gillinder Bedi, Richard W. Foltin, Erik W. Gunderson, Judith G. Rabkin, Carl L. Hart, Sandra D. Comer, Suzanne K. Vosburg, Margaret Haney> ;Psychopharmacology. 2010 Sep 8
• 32 citations
  Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial.
  Erik W. Gunderson, Xin-Qun Wang, David A. Fiellin, Benjamin Bryan, Frances R. Levin> ;Addictive Behaviors. 2010 May 1
• 98 citations
  Cocaine-Specific Antibodies Blunt the Subjective Effects of Smoked Cocaine in Humans
  Margaret Haney, Erik W. Gunderson, Huiping Jiang, Eric D. Collins, Richard W. Foltin> ;Biological Psychiatry. 2010 Jan 1
• 8 citations
  The Interface between Substance Abuse and Chronic Pain Management in Primary Care: A Curriculum for Medical Residents.
  Erik W. Gunderson, Phillip O. Coffin, Nancy Chang, Soteri Polydorou, Frances R. Levin> ;Substance Abuse. 2009 Jul 9
• 6 citations
  Impact of a Brief Training on Medical Resident Screening for Alcohol Misuse and Illicit Drug Use
  Erik W. Gunderson, Frances R. Levin, Patricia L. Owen> ;The American Journal on Addictions. 2008 Mar 4
• 32 citations
  Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?
  Erik W. Gunderson, David A. Fiellin> ;CNS Drugs. 2008 Jan 1
• 76 citations
  Acute Physiological and Behavioral Effects of Intranasal Methamphetamine in Humans
  Carl L. Hart, Erik W. Gunderson, Audrey Perez, Matthew G. Kirkpatrick, Andrew Thurmond, Sandra D. Comer, Richard W. Foltin> ;Neuropsychopharmacology. 2008 Jul 1
• 52 citations
  Modafinil attenuates disruptions in cognitive performance during simulated night-shift work.
  Carl L. Hart, Margaret Haney, Suzanne K. Vosburg, Sandra D. Comer, Erik W. Gunderson, Richard W. Foltin> ;Neuropsychopharmacology. 2006 Jul 1
• 84 citations
  Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.
  Margaret Haney, Judith G. Rabkin, Erik W. Gunderson, Richard W. Foltin> ;Psychopharmacology. 2005 Mar 19
• 10 citations
  Screening and Intervention for Alcohol and Illicit Drug Abuse: A Survey of Internal Medicine Housestaff
  Erik W. Gunderson, Frances R. Levin, Lawrence G. Smith> ;Journal of Addictive Diseases. 2005 Jan 1
• Join now to see all